Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

BioKryoBioKryo
VS
bioMérieuxbioMérieux
BioKryo

BioKryo

8, Avenue Gutenberg, Marne-la-Vallée, Île-de-France, 77600, FR

Last Update: 01/03/2026

View Profile
749/1000Moderate

BioKryo, Business Unit of Air Liquide Healthcare, offers tailor-made storage solutions to all structures confronted with a need in the management or the storage of biological samples. Member of European Business Unit Biobanking, BioKryo is a Biological Resource Cente...

NAICS:541714
NAICS Definition:Research and Development in Biotechnology (except Nanobiotechnology)
Employees:17
Subsidiaries:24
12-month incidents
0
Known data breaches
0
Attack type number
0
bioMérieux

bioMérieux

100, Allée Louis Pasteur, Marcy-l'Étoile, 69280, FR

Last Update: 01/04/2026

View Profile
Between 750 and 799
https://www.biomerieux.com
786/1000Fair

A family-owned company, bioMérieux has grown to become a world leader in the field of in vitro diagnostics. Our entrepreneurial adventure, begun over a century ago, is driven by an unrelenting commitment to improve public health worldwide. Since 1963, we've been pavin...

NAICS:541714
NAICS Definition:Research and Development in Biotechnology (except Nanobiotechnology)
Employees:12,827
Subsidiaries:6
12-month incidents
0
Known data breaches
0
Attack type number
1

Compliance Ranges Comparison

Based On Specific Ai Models Category
BioKryo

BioKryo

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
bioMérieux

bioMérieux

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for BioKryo in 2026.

Incidents

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for bioMérieux in 2026.

Incidents

Incident History - BioKryo (X = Date, Y = Severity)

BioKryo cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - bioMérieux (X = Date, Y = Severity)

bioMérieux cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
BioKryo

BioKryo

Incidents
No explicit notable incidents reported.
bioMérieux

bioMérieux

Incidents
🔒 Incident : Vulnerability
BIO305072725

FAQ

Between BioKryo company and bioMérieux company, which one has the best AI Cybersecurity Score ?
Between BioKryo company and bioMérieux company, which one has experienced more cyber incidents in the past ?
Between BioKryo company and bioMérieux company, which one has experienced more cyber incidents this year ?
Between BioKryo company and bioMérieux company, which one has experienced at least one ransomware attack ?
Between BioKryo company and bioMérieux company, which one has experienced at least one data breach ?
Between BioKryo company and bioMérieux company, which one has experienced at least one targeted cyberattack ?
Between BioKryo company and bioMérieux company, which one has experienced at least one vulnerability ?
Between BioKryo company and bioMérieux company, which one holds the most compliance certifications ?
Between BioKryo company and bioMérieux company, which one holds the fewest compliance certifications ?
Between BioKryo company and bioMérieux company, which one has the most subsidiaries ?
Between BioKryo company and bioMérieux company, which one has the largest number of employees ?
Between BioKryo and bioMérieux, which company holds both SOC 2 Type 1 certifications ?
Between BioKryo and bioMérieux, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - BioKryo or bioMérieux ?
Which company is PCI DSS compliant - BioKryo or bioMérieux ?
Between BioKryo and bioMérieux, which company complies with HIPAA regulations for healthcare data ?
Between BioKryo and bioMérieux, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-63261
SUMMARY

Uncontrolled Resource Consumption (CWE-400) in Kibana can lead to denial of service via Excessive Allocation (CAPEC-130). A low-privileged authenticated user can send a specially crafted request to a Kibana machine learning feature, causing the server to exhaust available memory and become unavailable to all users.

PUBLISHED
Date2026-07-21
UPDATED
Date2026-07-21
RISK INFORMATION (Score: 6.5)
CVSS3
Base Score: 6.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H
IMPACT SCORE
3.6
EXPLOITABILITY
2.8
CVE-2026-63260
SUMMARY

Uncontrolled Resource Consumption (CWE-400) in Kibana can lead to denial of service via Excessive Allocation (CAPEC-130). An authenticated attacker with low-privilege access can trigger a denial of service condition in Kibana by sending a specially crafted, oversized request payload. Processing this user-supplied input requires resource-intensive memory allocation that can exhaust the available heap memory in the Kibana process, causing it to crash and become unavailable to all users.

PUBLISHED
Date2026-07-21
UPDATED
Date2026-07-21
RISK INFORMATION (Score: 6.5)
CVSS3
Base Score: 6.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H
IMPACT SCORE
3.6
EXPLOITABILITY
2.8
CVE-2026-63259
SUMMARY

Authorization Bypass Through User-Controlled Key (CWE-639) in Kibana can lead to information disclosure via user-supplied identifiers that reference scheduled query result data from Kibana Spaces the requester is not authorized to access.

PUBLISHED
Date2026-07-21
UPDATED
Date2026-07-21
RISK INFORMATION (Score: 4.3)
CVSS3
Base Score: 4.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N
IMPACT SCORE
1.4
EXPLOITABILITY
2.8
CVE-2026-63145
SUMMARY

Incorrect Authorization (CWE-863) in Kibana can lead to integrity compromise of Machine Learning audit and notification records via Accessing Functionality Not Properly Constrained by ACLs (CAPEC-1). A vulnerability exists in Kibana's Machine Learning functionality where a Machine Learning management endpoint performs an insufficient authorization check. The endpoint validates only a coarse privilege level but does not verify that the requesting user has access to the specific Machine Learning job or notification resources provided in the request. As a result, a low-privileged user with Machine Learning access in any Kibana space can manipulate Machine Learning audit and notification records for arbitrary jobs—including jobs in other spaces or belonging to other users—by leveraging Kibana's internally elevated credentials to write to restricted Machine Learning system indices that the user cannot access directly.

PUBLISHED
Date2026-07-21
UPDATED
Date2026-07-21
RISK INFORMATION (Score: 4.3)
CVSS3
Base Score: 4.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:L/A:N
IMPACT SCORE
1.4
EXPLOITABILITY
2.8
CVE-2026-63144
SUMMARY

Uncontrolled Recursion (CWE-674) in Elasticsearch can lead to denial of service via a specially crafted search request submitted by a low-privileged authenticated user. A user with read-level index access can submit a request that triggers unbounded recursive processing within the Elasticsearch query evaluation component, causing a fatal error that terminates the affected node. In single-node deployments, this results in complete service outage; in multi-node clusters, it causes repeated node restarts and sustained availability degradation.

PUBLISHED
Date2026-07-21
UPDATED
Date2026-07-21
RISK INFORMATION (Score: 6.5)
CVSS3
Base Score: 6.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H
IMPACT SCORE
3.6
EXPLOITABILITY
2.8